Stockscreener 앱 받기
1.15
4.17%
-0.05
시장 영업 전:
1.15
전일 마감가:
$1.20
열려 있는:
$1.17
하루 거래량:
2.12M
Relative Volume:
1.21
시가총액:
$210.87M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-7.1875
EPS:
-0.16
순현금흐름:
$-9.61M
1주 성능:
+5.50%
1개월 성능:
-16.06%
6개월 성능:
-13.53%
1년 성능:
-48.66%
1일 변동 폭
$1.15
$1.23
1주일 범위
$1.05
$1.33
52주 변동 폭
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
(858) 251-4400
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.15 | 220.04M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 5.36B | 287.73M | 924.18M | 2.5229 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-09 | 개시 | H.C. Wainwright | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-23 | 개시 | CapitalOne | Overweight |
| 2024-03-13 | 재확인 | Needham | Buy |
| 2020-05-27 | 개시 | Guggenheim | Buy |
| 2020-02-20 | 재확인 | Needham | Buy |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-04-05 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2018-03-01 | 재확인 | Needham | Buy |
| 2018-01-03 | 개시 | Leerink Partners | Outperform |
| 2017-09-27 | 개시 | Northland Capital | Outperform |
| 2017-02-27 | 개시 | Needham | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-09-06 | 재개 | Lake Street | Buy |
| 2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
| 2015-12-10 | 개시 | Lake Street | Buy |
| 2015-09-23 | 재확인 | Leerink Partners | Outperform |
| 2015-09-02 | 개시 | BofA/Merrill | Buy |
| 2015-08-03 | 재확인 | Brean Capital | Buy |
| 2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
| 2015-06-19 | 재확인 | Leerink Partners | Outperform |
| 2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
What is Northland Securities' Forecast for HRTX Q1 Earnings? - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
HRTX Should I Buy - Intellectia AI
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2025 Earnings Call Transcript - Insider Monkey
What is HC Wainwright's Estimate for HRTX Q1 Earnings? - MarketBeat
HRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Heron Therapeutics: Profitable Growth Outlook and Acute Care Momentum Underpin Buy Rating and $3 Target - TipRanks
Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment - MSN
Heron Therapeutics Q4 Earnings Call Highlights - MarketBeat
Heron Therapeutics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HRTX) 2026-02-26 - Seeking Alpha
Key facts: Heron Therapeutics projects $173-$183M revenue by 2026; ZYNRELEF adoption rises; credit facilities expanded - TradingView
Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Heron Therapeutics, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com
Earnings call transcript: Heron Therapeutics Q4 2025 reports strong growth By Investing.com - Investing.com Canada
Heron Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
HRTX: 2025 net revenue rose 7.4% to $154.9M, with strong Acute Care growth and positive EBITDA - TradingView
HERON THERAPEUTICS ($HRTX) Releases Q4 2025 Earnings - Quiver Quantitative
Heron Therapeutics: Fourth Quarter Earnings Overview - Bitget
Heron Therapeutics: Q4 Earnings Snapshot - marketscreener.com
HERON THERAPEUTICS, INC. /DE/ SEC 10-K Report - TradingView
HRTX: 2025 net revenue rose 7.4% to $154.9M, driven by Acute Care growth and new CMS J-Codes - TradingView
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results - TradingView
Heron Therapeutics (HRTX) TTM Loss Of US$20.2 Million Tests Profitability Turnaround Narrative - Sahm
Aug Sectors: Whats Heron Therapeutics Incs historical returnWeekly Profit Recap & Technical Pattern Based Signals - baoquankhu1.vn
Heron Therapeutics Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring A Potential Upside Of 258.13% - DirectorsTalk Interviews
Heron Therapeutics, Inc. $HRTX Shares Acquired by JW Asset Management LLC - MarketBeat
Heron Therapeutics (HRTX) Expected to Announce Earnings on Thursday - MarketBeat
Aug EndMonth: What are JOFF Fintech Acquisition Corp Debt Equity Composite Unitss growth leversMarket Trend Report & Verified Entry Point Detection - baoquankhu1.vn
MSN Money - MSN
Heron: Near The Bottom Of A Trading Range Despite Positives (NASDAQ:HRTX) - Seeking Alpha
Clearline Capital reports 6.7% Heron Therapeutics stake (HRTX) - Stock Titan
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - The Manila Times
Should I set a stop loss on Heron Therapeutics Inc.Dollar Strength & Entry Point Confirmation Signals - mfd.ru
Can Heron Therapeutics Inc. expand into new marketsWeekly Risk Report & Breakout Confirmation Trade Signals - mfd.ru
How does Heron Therapeutics Inc. compare to its peersJuly 2025 Weekly Recap & Community Consensus Trade Alerts - mfd.ru
How strong is Heron Therapeutics Inc. (AXD2) stock earnings growthJuly 2025 WrapUp & Safe Capital Growth Tips - mfd.ru
How resilient is Heron Therapeutics Inc. stock in market downturnsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Here's Why Heron Therapeutics (NASDAQ:HRTX) Has A Meaningful Debt Burden - simplywall.st
Is Heron Therapeutics Inc. impacted by rising rates2025 Market Outlook & Weekly Hot Stock Watchlists - mfd.ru
Is Heron Therapeutics Inc. stock a good dividend stock2025 Analyst Calls & Daily Technical Stock Forecast Reports - mfd.ru
New York State Common Retirement Fund Buys 816,671 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Heron Therapeutics, Inc. (HRTX): Investor Outlook Reveals Potential 240.91% Upside - DirectorsTalk Interviews
Heron Therapeutics (NASDAQ:HRTX) & Enliven Therapeutics (NASDAQ:ELVN) Head to Head Contrast - Defense World
Heron Therapeutics (NASDAQ:HRTX) Shares Pass Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Heron Therapeutics (HRTX) awards EVP new RSUs and PSUs - Stock Titan
Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring A 238% Upside Potential - DirectorsTalk Interviews
Heron Therapeutics Inc (HRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Heron Therapeutics Inc 주식 (HRTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
5.71%
0.02%
자본화:
|
볼륨(24시간):